Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.22.1
STOCK-BASED COMPENSATION (Tables)
 3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award The following table contains information about the Company's equity incentive plans as of March 31, 2022:
Awards Reserved for Issuance Awards Exercised Awards Outstanding Awards Available for Grant
2016 Equity Incentive Plan 999,906  —  499,953  499,953 
2018 Equity Incentive Plan 30,159,437  4,080,088  14,009,842  12,069,507 
2019 Equity Incentive Plan 101,475,719  54,383  73,014,714  28,406,622 
Share-based Payment Arrangement, Option, Activity
The following table summarizes the Company’s stock option activity and related information for the three months ended March 31, 2022:
Number of
Shares
Weighted-
Average Exercise
Price Per Share 		Weighted-
Average
Remaining
Contractual
Life 		Aggregate
Intrinsic
Value of
In-the-Money
Options
 
Options outstanding as of January 1, 2022 88,251,380 $ 0.20 
Exercised (146,212) $ 0.08 
Forfeited (223,788) $ 0.15 
Expired (29,762) $ 0.34 
Options outstanding as of March 31, 2022
 87,851,618 $ 0.20  8.5 years $ 526 
Options exercisable as of March 31, 2022
 41,296,676 $ 0.26   7.4 years $ 1,338 
Share-based Payment Arrangement, Activity
The following table sets forth the total stock-based compensation expense resulting from stock options and restricted grants of common stock to employees, directors and non-employee consultants in the consolidated statement of operations which are included in selling, general and administrative expenses:
  (in thousands except for shares / options)
  For the Three Months Ended
  March 31, 2022 March 31, 2021
Type of Award Number of
Shares or
Options
Granted		 Stock-Based
Compensation
Expense 		Number of
Shares or
Options
Granted		 Stock-Based
Compensation
Expense
 
Stock options 114,006,195 $ 1,821  500,000 $ 244 
Stock grants:
Employees (common stock) 900,000  $ 182  — — 
Directors (common stock) 683,332 $ 184  541,666 121 
Non–employee consultants (common stock) — $ —  332,947 33 
Total stock–based compensation expense $ 2,187  $ 398